戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 kidney disease that is an important cause of end stage renal failure.
2 ar filtration barrier are a leading cause of end stage renal failure.
3 nts suffering insulin-dependent diabetes and end stage renal failure.
4 standard for some patients with diabetes and end stage renal failure.
5 ication of diabetes and the leading cause of end-stage renal failure.
6 fections, crescentic glomerulonephritis, and end-stage renal failure.
7 ause of acute kidney injury that can lead to end-stage renal failure.
8 gression of renal failure and the time until end-stage renal failure.
9 s associated with chronic kidney disease and end-stage renal failure.
10 f most chronic kidney disease progression to end-stage renal failure.
11 e are the optimum form of vascular access in end-stage renal failure.
12 transplantation is the optimum treatment for end-stage renal failure.
13  a major clinical problem that can result in end-stage renal failure.
14                 SRNS regularly progresses to end-stage renal failure.
15 ve treatment, and patients often progress to end-stage renal failure.
16  the best treatment option for patients with end-stage renal failure.
17 g to chronic kidney disease and occasionally end-stage renal failure.
18 n patients with type 1 diabetes mellitus and end-stage renal failure.
19 rotic syndrome (SRNS) is a frequent cause of end-stage renal failure.
20 eatment of choice for diabetic patients with end-stage renal failure.
21 treatment of hematological malignancies with end-stage renal failure.
22 ammatory syndromes and frequently results in end-stage renal failure.
23 opment of proteinuria and the progression to end-stage renal failure.
24 ysplasia is the principal cause of childhood end-stage renal failure.
25 , and atherosclerosis, the leading causes of end-stage renal failure.
26 and pharmacodynamics of RTX in patients with end-stage renal failure.
27 ountered forms of renal disease that lead to end-stage renal failure.
28 lomerulosclerosis, which ultimately leads to end-stage renal failure.
29 ier initiation of dialysis for patients with end-stage renal failure.
30 sion of chronic renal diseases that leads to end-stage renal failure.
31 tely limit the use of peritoneal dialysis in end-stage renal failure.
32 s 1 in 1000 individuals and often results in end-stage renal failure.
33   Diabetic nephropathy is a leading cause of end-stage renal failure.
34  renal replacement therapy for children with end-stage renal failure.
35 rogression to overt nephropathy and eventual end-stage renal failure.
36 tion and is essential for the progression to end-stage renal failure.
37 isease is the most common cause of childhood end-stage renal failure, a condition that is lethal with
38 fficiency in affected patients progresses to end-stage renal failure, a highly morbid state requiring
39 ischemic kidney damage, acute kidney injury, end-stage renal failure, acute renal transplant rejectio
40                    KTx should be offered for end-stage renal failure after LTx, even in the presence
41                                              End-stage renal failure after successful liver transplan
42 ohort study of outcomes in 221 patients with end-stage renal failure aged 70 years or over recruited
43 dly affects glomeruli and progresses towards end stage renal failure and multiple organ dysfunction.
44 man EPO (rHuEPO) for anaemia associated with end-stage renal failure and cancer chemotherapy, also ha
45 lthy individuals and patients with diabetes, end-stage renal failure and familial hypercholesterolaem
46 ciated with apoAI Gly26Arg, which had led to end-stage renal failure and progressive liver dysfunctio
47  consecutive AAGN patients who had developed end-stage renal failure and received a kidney allograft
48  tubulointerstitial nephritis culminating in end-stage renal failure and urothelial malignancy.
49 kidney disease (DKD) is the leading cause of end-stage renal failure, and current interventions fail
50 ssive kidney fibrosis contributes greatly to end-stage renal failure, and no specific treatment is av
51 ns unanswered whether diabetic patients with end-stage renal failure are better served by LRD or SPK.
52        The leading causes of albuminuria and end-stage renal failure are secondary to abnormalities i
53 n 66 patients with abnormal bladders who had end-stage renal failure as a consequence of urologic abn
54     Nine patients (47.4%) had a diagnosis of end-stage renal failure at presentation.
55 velopment of both chronic kidney disease and end-stage renal failure, but the molecular details under
56 se mice developed proteinuria at 3 weeks and end stage renal failure by 5 weeks after birth.
57                                              End stage renal failure can be seen very rare.
58                   The rate of progression to end-stage renal failure can be delayed, but progression
59    By 3 weeks of age the mice develop severe end stage renal failure characterized by both tubulointe
60 e of soluble CR1 in a pediatric patient with end stage renal failure demonstrated its safety and abil
61 st prevalent monogenetic disorder leading to end-stage renal failure (ESRD) in childhood.
62      Clinical practice guidelines (CPGs) for end-stage renal failure (ESRD) were recently published,
63                    Eleven patients (24%) had end-stage renal failure (ESRF) at presentation; of these
64 ber of patients with hypertension-associated end-stage renal failure (ESRF) continues to increase des
65 reditary glomerulonephritis which results in end-stage renal failure (ESRF) in most cases.
66 cause renal dysfunction that may progress to end-stage renal failure (ESRF).
67 /6J is a protective background and postpones end stage renal failure from 7 weeks, as seen on a C3H b
68 ) disease are at risk for the development of end-stage renal failure from the treatment of localized
69                      For those patients with end-stage renal failure, GCV concentrations fell during
70              The growth in the prevalence of end-stage renal failure has been accompanied with a rise
71 patients could be decreased before and after end-stage renal failure has occurred.
72 nical renal involvement rarely progresses to end-stage renal failure; however, recent studies suggest
73 r common finding in kidneys that progress to end-stage renal failure; however, the effect of HGF on i
74 k factors of upper limb ischemia - diabetes, end-stage renal failure, hyperparathyroidism, or even sy
75 R) and urinary tract infection can result in end-stage renal failure, hypertension, or both.
76 shed reports of transplantation secondary to end-stage renal failure in adult patients with systemic
77 e urinary tract are the most common cause of end-stage renal failure in children and account for a si
78  reflux nephropathy (RN) causes up to 15% of end-stage renal failure in children and adults.
79 dder outflow obstruction is a major cause of end-stage renal failure in children and is associated wi
80 nstitute the most frequent genetic cause for end-stage renal failure in children and young adults.
81 n terms of pediatric health care costs, with end-stage renal failure in children estimated to cost >$
82 sease, is the most frequent genetic cause of end-stage renal failure in children.
83 ADPKD) is the most common monogenic cause of end-stage renal failure in humans and results from germl
84 sease, is the most frequent genetic cause of end-stage renal failure in the first three decades of li
85 recessive cystic renal disease that leads to end-stage renal failure in the first two decades of life
86 nephropathy (DN) became the leading cause of end-stage renal failure in the Western world.
87 th atrial fibrillation include patients with end-stage renal failure (including those receiving dialy
88 targeted treatments are lacking, progress to end stage renal failure is a common final outcome.
89                                  The rate of end-stage renal failure is disproportionately high in th
90 he prevalence of atrial fibrillation (AF) in end-stage renal failure is high, with an increased risk
91 l function in most patients, and the risk of end-stage renal failure is low.
92 e and progression of cyclosporine-associated end-stage renal failure necessitating chronic hemodialys
93  chronic kidney disease (CKD) and consequent end-stage renal failure necessitating renal replacement
94                                Patients with end-stage renal failure need arteriovenous fistulas (AVF
95                                              End stage renal failure occurred in 23 children, 6 of wh
96 veloped nephrotic syndrome and progressed to end-stage renal failure over 1.5 years.
97 tanes were found to be 8.3-fold higher in an end-stage renal failure patient on hemodialysis and urin
98 OxPL in human peritoneal dialysis fluid from end-stage renal failure patients inhibited phagocytosis
99                Of these, 19 (6.5%) developed end-stage renal failure requiring chronic hemodialysis.
100  bone marrow pathology, haemochromatosis, or end-stage renal failure requiring dialysis.
101 ths after transplantation and progression to end-stage renal failure, requiring hemodialysis in 6.5%
102                     Three patients developed end-stage renal failure secondary to calcineurin nephrot
103                                           In end-stage renal failure, the net clinical benefit of VKA
104 ugh Col4a3;Tsp1 DKO mice did progress toward end-stage renal failure, their kidneys exhibited distinc
105 idney donors must be paramount in addressing end-stage renal failure through living kidney donation.
106                 It has enabled patients with end-stage renal failure to survive for years, in many ca
107             Twenty-two patients with T1D and end-stage renal failure undergoing islet transplantation
108                            The median age at end stage renal failure was 22.5 years (range, 10-38 yea
109 atients with combined MCP mutation developed end stage renal failure within 3 years from onset compar
110 deterioration of kidney function, leading to end-stage renal failure within 3 years.
111 s nephronophthisis, typically progressing to end-stage renal failure within the first two decades of

 
Page Top